Código QR (código de barras bidimensional)

Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study

Background and aim: Sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucose-lowering drugs that increase urinary glucose excretion have been shown to reduce CV events in patients with type 2 diabetes (T2D). Furthermore, several studies have demonstrated that treatment with SGLT2 inhibitors affect...

ver descrição completa

Na minha lista:
Principais autores: Matthias Rau, Kirsten Thiele, Niels-Ulrik Korbinian Hartmann, Julia Möllmann, Stephanie Wied, Mathias Hohl, Nikolaus Marx, Michael Lehrke
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-06-01
coleção:Bone Reports
Assuntos:
Type 2 diabetes
SGLT2 inhibitors
Empagliflozin
Serum phosphate
FGF23
PTH
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2352187222000109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados